🔎 Trials Near Me

Hjem › Melanom › Illinois › Chicago

Kliniske studier for Melanom i Chicago, IL

15 studier for Melanom søker deltakere på steder i og rundt Chicago (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
  • Mount Sinai Hospital Medical Center, Chicago
  • John H Stroger Jr Hospital of Cook County, Chicago
  • University of Illinois, Chicago
  • og 1 flere
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

RekruttererFase 2
  • University of Illinois Cancer Center, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06172478

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

RekruttererFase 2
  • Northwestern University, Chicago
  • University of Illinois, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT05136196

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

RekruttererFase 3
  • Northwestern University, Chicago
  • Swedish Covenant Hospital, Chicago
Alder 75 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT07068074

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

RekruttererFase 1/2
  • Northwestern University, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 31. aug. 2026 · NCT05896839

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

RekruttererFase 1/2
  • Lurie Children's Hospital-Chicago, Chicago
12 Months – 30 Years · Alle kjønn · Oppdatert 25. aug. 2026 · NCT04851119

Project: Every Child for Younger Patients With Cancer

RekruttererObservasjonsstudie
  • Lurie Children's Hospital-Chicago, Chicago
  • Northwestern University, Chicago
  • University of Illinois, Chicago
  • og 1 flere
Opp til 25 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT02402244

Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions

Rekrutterer
  • Northwestern University, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 10. jul. 2026 · NCT07556380

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

RekruttererFase 1/2
  • Call for Information (Investigational Site 0024), Chicago
6 Months – 17 Years · Alle kjønn · Oppdatert 6. jul. 2026 · NCT02332668

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

RekruttererFase 1/2
  • University of Chicago Medical Center, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 13. mai 2026 · NCT03686124

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

RekruttererFase 2/3
  • Northwestern Memorial Hospital, Chicago
  • University of Chicago Medical Center, Chicago
Alle aldre · Alle kjønn · Oppdatert 2. apr. 2026 · NCT06581406

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

RekruttererObservasjonsstudie
  • John H Stroger Jr Hospital of Cook County, Chicago
  • Advocate Illinois Masonic Medical Center, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 17. mar. 2026 · NCT06418204

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RekruttererObservasjonsstudie
  • Massive Bio SYNERGY-AI site, Chicago
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Rekrutterer
  • Advocate Illinois Masonic Medical Center, Chicago
Alder 18 og eldre · Alle kjønn · Oppdatert 27. nov. 2024 · NCT03860883

Melanom-studier i andre byer

Andre studier i Chicago

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.